Editas Medicine Inc - EDIT - stock price prediction, stock price target, analyst ratings from 13 analysts

Editas Medicine Inc has a share price target of US$ 6, revenue growth forecast of -65.1%, and profit growth estimate of 28.3% for FY26, based on top 13 analyst calls.